RecruitingNCT07130565

Pan-Amyloid PET/CT in Various Amyloid-Related Disease

Sponsor

Tianjin Medical University

Enrollment

500 participants

Start Date

Nov 1, 2023

Study Type

OBSERVATIONAL

Conditions

Amyloidosis Cardiac Amyloidosis Amyloid

Summary

To evaluate the potential usefulness of 18F-92/AV45/TPZA/FT8, 11C-PIB positron emission tomography/computed tomography (PET/CT) for the diagnosis of primary and metastatic lesions in various Pan-Amyloid-related disease patients.

Eligibility

Min Age: 18 YearsMax Age: 80 Years

Plain Language Summary

Simplified for easier understanding

This study is evaluating a newer type of PET/CT scan — called a Pan-Amyloid scan — that can detect abnormal protein buildup (amyloid) in different tissues, especially the heart, in people with suspected or confirmed amyloid-related disease. **You may be eligible if...** - You are 18 or older - You have suspected or confirmed cardiac amyloidosis (amyloid buildup in the heart), supported by MRI, CT, blood tests, or a biopsy - You are already scheduled for a Pan-Amyloid PET/CT scan - You are able to give written consent (or have a parent/legal guardian who can) **You may NOT be eligible if...** - You do not have an amyloid-related condition (the lesion has a different cause) - You are pregnant - You are unwilling or unable to provide written consent Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.